Marlborough Research Centre announces new chief executive
A “generalist with a commercial background” is the new boss at MRC, taking over from Gerald Hope on July 1. 
© 2024 Stuff.co.nz Wed 3:25pm AFT broadens R&D pipeline with new product candidate
AFT Pharmaceuticals (ASX: AFP, NZX: AFT) today announces that it has entered into a partnership with one of its research and development partners, Belgium’s Hyloris Pharmaceuticals. to develop a novel locally acting product for the treatment of Burn
© 2024 sharechat.co.nz Fri, 22 Dec 1:52pm GNE - Genesis selects Gentrack g2.0
Genesis Energy (NZX/ASX: GNE) has selected Gentrack (NZX/ASX: GTK) g2.0 to enable a digital transformation focused on delivering an enhanced customer experience
© 2024 sharechat.co.nz Mon, 20 Nov 12:08am GNE - Review of Retail Operating Model
Genesis Energy today announced that it has commenced a review of its retail operating model. Subject to the outcome of the review process, a reduction of around 200 roles across FY24 and FY25 may result
© 2024 sharechat.co.nz Fri, 20 Oct 11:43am Genesis delivers solid earnings and emissions reduction
Genesis Energy delivered a strong financial performance in FY23 with EBITDAF of $523.5 million built on growth across all customer brands and improved margins while reducing emissions
© 2024 sharechat.co.nz Thu, 24 Aug 11:10am  Genesis to redeem GNE050 Capital Bonds
Genesis Energy Limited (Genesis) announces that it is exercising its option to fully redeem its subordinated capital bonds which are quoted on the NZX Debt Market under the ticker GNE050 (GNE050 Bonds) on 17 July 2023
© 2024 sharechat.co.nz Fri, 30 Jun 11:20am Genesis Energy Considers Green Capital Bond Offer
Genesis Energy Limited (Genesis) is considering making an offer (Offer) of 30 year unsecured, subordinated green capital bonds (Capital Bonds) to New Zealand investors
© 2024 sharechat.co.nz Mon, 19 Jun 11:46am Genesis Appoints Chief People Officer
Genesis Energy is today confirming the appointment of Claire Walker as Chief People Officer (CPO). She will commence her role on 3 April 2023
© 2024 sharechat.co.nz Mon, 19 Dec 11:40am General Capital (GEN:NZ) Announces Discussions on Goodwill
Listed financial services group General Capital (GEN:NZ) advises it is in discussion with the FMA concerning the carrying value of Investment Research Group Ltd (IRG) in the books of General Capital. IRG was purchased in August 2017 for $1.0m
© 2024 sharechat.co.nz Thu, 17 Nov 12:01am  |
|
 |
 
GNE - Resignation of Chief Financial Officer
Genesis Energy advises that Chief Financial Officer, James Spence, is leaving the company due to family reasons, effective from 24 May and will take up a new role in Australia. James moved to New Zealand from Australia with his family to join Genesis Ener
© 2024 sharechat.co.nz Fri, 16 Feb 11:45am Genesis Energy launches new strategy
Genesis Energy to use Kupe profits to deliver 95% renewable generation by 2035 under strategy reset
© 2024 sharechat.co.nz Thu, 30 Nov 10:28am  Genesis Energy - Huntly Unit 5 Outage Update
Genesis has been actively pursuing options to return Huntly Unit 5 to service. Successful negotiations with third parties have resulted in an accelerated return to service which we now expect to be 31 January 2024.
© 2024 sharechat.co.nz Mon, 18 Sep 1:25pm Huntly Unit 5 Outage Extended
Further investigation into Genesis’ Huntly Unit 5 combined cycle gas plant outage has indicated that return to service is now expected in late May 2024, as circuit breaker components are manufactured internationally
© 2024 sharechat.co.nz Fri, 4 Aug 3:50pm Genesis Appoints Chief Transformation & Technology Officer
Genesis is today confirming the appointment of Edward Hyde as Chief Transformation & Technology Officer. He will commence his role on 4 September 2023
© 2024 sharechat.co.nz Mon, 17 Jul 4:00pm GNE - Genesis Appoints Chief Customer Officer
Genesis is today confirming the appointment of Stephen England-Hall as Chief Customer Officer (CCO). He will commence his role on 31 July 2023
© 2024 sharechat.co.nz Tue, 27 Jun 3:25pm  Pictor announces seroprevalence study using novel SARS-CoV-2 Antibody Test to assess Kiwis’ antibody levels
AUCKLAND, New Zealand – Pictor, a global leader in immunodiagnostics, today announced an important research project – the Pictor Antibody Clinical Trial (PACT-19) – which aims to gain important information and insights into the COVID-19
© 2024 sharechat.co.nz Thu, 22 Dec 12:47am
|
|
